FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects

BMC Bioinformatics

Volumn 9, Issue , 2008, Pages

  Lagorce, David ^a   Sperandio, Olivier ^a   Galons, Hervé ^a   Miteva, Maria A ^a   Villoutreix, Bruno O ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADMET PROPERTIES; CHEMICAL BIOLOGY; COMPOUND COLLECTIONS; COMPOUND LIBRARIES; DISTRIBUTION DIAGRAM; PHYSICOCHEMICAL PROPERTY; UNSTABLE MOLECULES; VIRTUAL SCREENING;

TOOLS;

FUNCTIONAL GROUPS;

ANILINE DERIVATIVE; ANTIANDROGEN; BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; FLUTAMIDE; HYDRAZINE; NILUTAMIDE; NITRAZEPAM; SULFAMETHOXAZOLE; TACRINE; DRUG;

ARTICLE; CALCULATION; CARCINOGENESIS; COMPUTER MODEL; COMPUTER PROGRAM; DECISION MAKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG RESEARCH; HUMAN; HUMAN COMPUTER INTERACTION; LIVER TOXICITY; PHYSICAL CHEMISTRY; PREDICTION; SCREENING; TOXICITY; ALGORITHM; BIOCHEMISTRY; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DRUG DESIGN; METHODOLOGY; RESEARCH;

ALGORITHMS; BIOCHEMISTRY; COMPUTER SIMULATION; DRUG DESIGN; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; RESEARCH; SOFTWARE;

EID: 53349145331     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-9-396     Document Type: Article

References (41)

1. Selick HE Beresford AP Tarbit MH The emerging importance of predictive ADME simulation in drug discovery Drug Discov Today 2002, 7(2):109-116. 10.1016/S1359-6446(01)02100-6 11790621
2. Kubinyi H Drug research: Myths, hype and reality Nat Rev Drug Discov 2003, 2(8):665-668. 10.1038/nrd1156 12904816
3. Lyne PD Structure-based virtual screening: An overview Drug Discov Today 2002, 7(20):1047-1055. 10.1016/S1359-6446(02)02483-2 12546894
4. Oprea TI Davis AM Teague SJ Leeson PD Is there a difference between leads and drugs? A historical perspective J Chem Inf Comput Sci 2001, 41(5):1308-1315. 11604031
5. Teague SJ Davis AM Leeson PD Oprea T The Design of Leadlike Combinatorial Libraries Angew Chem Int Ed Engl 1999, 38(24):3743-3748. 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID- ANIE3743>3.0.CO;2-U 10649345
6. Beresford AP Segall M Tarbit MH In silico prediction of ADME properties: are we making progress? Curr Opin Drug Discov Devel 2004, 7(1):36-42. 14982146
7. Lipinski CA Lombardo F Dominy BW Feeney PJ Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 2001, 46(1-3):3-26. 10.1016/S0169-409X(00)00129-0 11259830
8. Veber DF Johnson SR Cheng HY Smith BR Ward KW Kopple KD Molecular properties that influence the oral bioavailability of drug candidates J Med Chem 2002, 45(12):2615-2623. 10.1021/jm020017n 12036371
9. Oprea TI Property distribution of drug-related chemical databases J Comput Aided Mol Des 2000, 14(3):251-264. 10.1023/A:1008130001697 10756480
10. Miteva MA Violas S Montes M Gomez D Tuffery P Villoutreix BO FAF-Drugs: free ADME/tox filtering of compound collections Nucleic Acids Res 2006, 34: Web Server W738-744. 1538885 16845110 10.1093/nar/gkl065
11. Egan WJ Merz KM Jr Baldwin JJ Prediction of drug absorption using multivariate statistics J Med Chem 2000, 43(21):3867-3877. 10.1021/ jm000292e 11052792
12. Rishton GM Reactive compounds and in vitro fake positives in HTS Drug Discov Today 1997, 2(9):382-384. 10.1016/S1359-6446(97)01083-0
13. Rishton GM Nonleadlikeness and leadlikeness in biochemical screening Drug Discov Today 2003, 8(2):86-96. 10.1016/S1359644602025722 12565011
14. Roche O Schneider P Zuegge J Guba W Kansy M Alanine A Bleicher K Danel F Gutknecht EM Rogers-Evans M et al.: Development of a virtual screening method for identification of "frequent hitters" in compound libraries J Med Chem 2002, 45(1):137-142. 10.1021/jm010934d 11754585
15. McGovern SL Helfand BT Feng B Shoichet BK A specific mechanism of nonspecific inhibition J Med Chem 2003, 46(20):4265-4272. 10.1021/ jm030266r 13678405
16. Seidler J McGovern SL Doman TN Shoichet BK Identification and prediction of promiscuous aggregating inhibitors among known drugs J Med Chem 2003, 46(21):4477-4486. 10.1021/jm030191r 14521410
17. Sirois S Hatzakis G Wei D Du Q Chou KC Assessment of chemical libraries for their druggability Comput Biol Chem 2005, 29(1):55-67. 10.1016/ j.compbiolchem.2004.11.003 15680586
18. Hann M Hudson B Lewell X Lifely R Miller L Ramsden N Strategic pooling of compounds for high-throughput screening J Chem Inf Comput Sci 1999, 39(5):897-902. 10529988
19. Pearce BC Sofia MJ Good AC Drexler DM Stock DA An empirical process for the design of high-throughput screening deck filters J Chem Inf Model 2006, 46(3):1060-1068. 10.1021/ci050504m 16711725
20. O'Boyle NM Morley C Hutchison GR Pybel: A Python wrapper for the OpenBabel cheminformatics toolkit Chem Cent J 2008, 2:5. 2270842 18328109 10.1186/1752-153X-2-5
21. OpenBabel Open Babel 2.1.1 Open Babel 2.1.1 edn 2008 http://openbabel.org/wiki/Main_Page
22. Daylight Chemical Information Systems Inc SMARTS - A Language for Describing Molecular Patterns 120 Vantis - Suite 550 - Aliso Viejo, CA 92656 2007.
23. Ertl P Rohde B Selzer P Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J Med Chem 2000, 43(20):3714-3717. 10.1021/jm000942e 11020286
24. McGovern SL Caselli E Grigorieff N Shoichet BK A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J Med Chem 2002, 45(8):1712-1722. 10.1021/jm010533y 11931626
25. Wildman SA Crippen CG Prediction of physicochemical parameters by atomic contributions J Chem Inf Comput Sci 1999, 39:868-873.
26. Wang R Calculating partition coefficient by atom-additive method Perspectives in Drug Discovery and Design 2000, 19:47-66. 10.1023/ A:1008763405023
27. SD File format MDL - Symix 2007 http://www.mdl.com/downloads/public/ ctfile/ctfile.pdf
28. ChemBridge 2008 http://www.chembridge.com/ collected-screening-libraries.html
29. Gultekin F Hicyilmaz H Renal deterioration caused by carcinogens as a consequence of free radical mediated tissue damage: A review of the protective action of melatonin Arch Toxicol 2007, 81(10):675-681. 10.1007/s00204-007-0242-1 17823789
30. Metosh-Dickey CA Mason RP Winston GW Nitroarene reduction and generation of free radicals by cell-free extracts of wild-type, and nitroreductase-deficient and -enriched Salmonella typhimurium strains used in the umu gene induction assay Toxicol Appl Pharmacol 1999, 154(2):126-134. 10.1006/taap.1998.8573 9925796
31. Boelsterli UA Ho HK Zhou S Leow KY Bioactivation and hepatotoxicity of nitroaromatic drugs Curr Drug Metab 2006, 7(7):715-727. 10.2174/ 138920006778520606 17073576
32. Tafazoli S Mashregi M O'Brien PJ Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model Toxicol Appl Pharmacol 2008, 229(1):94-101. 10.1016/j.taap.2008.01.002 18295292
33. Neumann HG Aromatic amines in experimental cancer research: tissue-specific effects, an old problem and new solutions Crit Rev Toxicol 2007, 37(3):211-236. 10.1080/10408440601028603 17453932
34. Walraven JM Trent JO Hein DW Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1 Drug Metab Rev 2008, 40(1):169-184. 2265210 18259988 10.1080/03602530701852917
35. Kim D Guengerich FP Cytochrome P450 activation of arylamines and heterocyclic amines Annu Rev Pharmacol Toxicol 2005, 45:27-49. 10.1146/ annurev.pharmtox.45.120403.100010 15822170
36. Patocka J Jun D Kuca K Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease Curr Drug Metab 2008, 9(4):332-335. 10.2174/138920008784220619 18473751
37. Bemis GW Murcko MA Properties of known drugs. 2. Side chains J Med Chem 1999, 42(25):5095-5099. 10.1021/jm9903996 10602694
38. Jones DJ Lamb JH Verschoyle RD Howells LM Butterworth M Lim CK Ferry D Farmer PB Gescher AJ Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity Br J Cancer 2004, 91(6):1213-1219. 15292928
39. Wishart DS Knox C Guo AC Cheng D Shrivastava S Tzur D Gautam B Hassanali M DrugBank: A knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res 2008, 36: Database D901-906. 2238889 18048412
40. Wishart DS Knox C Guo AC Shrivastava S Hassanali M Stothard P Chang Z Woolsey J DrugBank: A comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res 2006, 34: Database D668-672. 1347430 16381955 10.1093/nar/gkj067
41. Di L Kerns EH Profiling drug-like properties in discovery research Curr Opin Chem Biol 2003, 7(3):402-408. 10.1016/S1367-5931(03)00055-3 12826129